Scienza e Tecnologia
Global Market for Media, Sera, and Reagents in Biotechnology to Reach $9.3 Billion byc
This report analyzes the current and future markets for media, sera, and reagents in biotechnology, highlighting trends, opportunities, and challenges. It covers emerging technologies, patents, ESG developments, funding, and industry deals, with market forecasts through 2029. The market is segmented by product type (reagents, media, and sera), end users (biopharmaceutical companies, research institutes, and contract research organizations), and regions ( North America , Europe , Asia-Pacific , and the Rest of the World). It also provides insights into leading companies' strategies, their financials, product portfolios, and recent developments. Historical data (2021-2022), the base year (2023), and projections up to 2029 are included.
The growing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular conditions, is increasing the need for treatments and healthcare solutions. This trend is driving advances in medical research, biotechnology, and pharmaceutical developments worldwide.
Growing investments in biopharmaceuticals are fueling innovation in drug development, gene therapy, and personalized medicine. This surge in funding is driving advances in biotechnology, improving treatment options for various diseases.
The rising demand for personalized medicine is revolutionizing healthcare by tailoring treatments to individual genetic profiles. This shift is driving advances in biotechnology, diagnostics, and targeted therapies.
Rapid technological advances are transforming industries by enhancing efficiency, innovation, and automation. These breakthroughs drive progress in biotechnology, healthcare, and other sectors, improving products and services worldwide.
• Increasing demand for personalized medicines.
• Technological advances.
The growing approvals for biologics, particularly monoclonal antibodies, along with advances in regenerative therapies like cell and gene therapies, are driving demand for cell culture media, sera, and reagents. Additionally, the expanding biologics pipeline and rising investments are fueling the need for increased biomanufacturing capacity, further boosting demand for cell culture products.
The global market for media, sera, and reagents in biotech was valued at $5.9 billion in 2023 and is forecast to grow at a CAGR of 8.1% from 2024 to 2029.
The growth of the global market for media, sera, and reagents in biotech is due to the world's rising aging population and prevalence of chronic diseases, increased investments in the biopharmaceutical industry, demand for personalized medicine, and technological advances.
The global market for media, sera, and reagents is segmented based on product type, end-user and region.
The reagents segment will be dominant through the forecast period.
North America holds the largest share of the market.
The global market for industrial enzymes is expanding, driven by their growing use in food processing, biofuels, pharmaceuticals, and other industries. Advances in biotechnology and sustainability efforts are further boosting demand for enzyme-based solutions.
For further information on any of these reports or to make a purchase, contact info@bccresearch.com.
BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.
Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109,
USA
Email: info@bccresearch.com
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.
Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.
Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-market-for-media-sera-and-reagents-in-biotechnology-to-reach-9-3-billion-byc-302495835.html